Early access
Sign in
Taking people in United StatesNo phase

Weekly online symptom reports from adults being treated for breast, lung, ovarian, blood cancers

Collects weekly online symptom reports from adults on active cancer treatment.

Key facts

Who runs it
Carevive Systems, Inc.
Where
Canton, Chapel Hill, Cleveland, Durham, Evanston, Massillon, and New Haven, United StatesSee the 7 sites
Trial code
Registry title
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Status
Recruiting
People taking part
25 people, planned
Started
19 Jul 2023
Expected to end
31 Dec 2026
Type of study
Observational
Treatments tested
  • Web based survey
Record updated
30 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with breast, lung, ovarian cancer, multiple myeloma or AML who can answer weekly online symptom surveys in English.

Age
18 years or older
Sex
All sexes can join
Disease stage
Breast, lung or ovarian cancer, multiple myeloma, or acute myelogenous leukemia (AML), at any stage and anywhere in the treatment course

Main reasons for not taking part

  • Cannot understand written or spoken English
  • Cannot complete online surveys on a cell phone, tablet or computer
  • Is on a treatment clinical trial
  • Prisoners and other vulnerable persons as defined by NIH

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • All participants must be 18 years of age or older
  • Subjects may be any stage and anywhere in the treatment continuum
  • Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma
  • Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer
  • All participants must be able to understand English

Who cannot take part

  • Any patient who cannot understand written or spoken English
  • Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer
  • Any patient on a treatment clinical trial
  • Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D)

Where in United States

  • Cleveland Clinic Mercy HospitalCanton, United StatesContact: Janet MuckleyTaking people
  • Univeristy of North Carolina at Chapel HillChapel Hill, United StatesContact: JULIE SCOTT, MSNNo longer taking part
  • University Hospitals Seidman Cancer CenterCleveland, United StatesContact: Jill Severino-Powell, MSNTaking people
  • DukeDurham, United StatesContact: JULIE SCOTT, MSNNo longer taking part
  • Northshore University Health SystemEvanston, United StatesContact: Michele BrittoTaking people
  • Tri-County Hematology & Oncology Associates, Inc.Massillon, United StatesContact: Janet MuckleyTaking people
  • Yale Cancer CenterNew Haven, United StatesContact: JULIE SCOTT, MSNNo longer taking part

About the trial

What the trial wants to find out

The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment.

Read full original descriptionShow less

Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.

Treatments tested

  • Web based survey

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring
Plain-language title
Weekly online symptom reports from adults being treated for breast, lung, ovarian, blood cancersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
30 October 2026